A range of welfare measures, monthly financial aid for women, loan waivers for farmers and caste-based census feature in the Opposition alliance’s manifesto  

This model integrates data from various sources, including a continuous glucose monitor (CGM), activity trackers, and a smartphone app where patients log their daily food intake

Omicron might dent growth, but the long-term outlook seems promising

They are designed to make a patient’s immune system attack tumours

In its old form, the antibiotic is very safe for use but it lacks the necessary antibacterial activity against many bacterial pathogens.

The service, which has been under testing in Delhi NCR, is now available in Mumbai, Bangalore, Hyderabad, and Pune, with plans for expansion to additional cities

The teaser of director Sujeeth and Pawan Kalyan’s ‘They call him OG’ reveals an action entertainer set in Mumbai

Kharge says PM has a history of making false promise

National Bureau of Economic Research

In the last 9 months alone, 1,933 Maharashtra farmers took their lives, a stark testament to the ongoing agrarian crisis that remains untouched by political promises 

Addressing a public rally in Jaffna in the Northern Province, Sri Lanka’s recently elected President assures conduct of provincial and local body elections; revival of industries in war-affected areas

Many top companies are willing to invest in Andhra Pradesh as they believe in the government’s commitment and consistency in its policies, says Chandrababu Naidu

The former Minister appeals to all graduates of erstwhile Krishna and Guntur districts to as voters in the ensuing MLC elections and vote him to power

UPS addresses concerns of both employees and the fisc

He lays foundation stone for Padmasali Bhavan to be constructed by Padmasali International Welfare Association at Kolanukonda

There can be no further delay in restoring Statehood for Jammu and Kashmir

Former Union Minister Anurag Thakur takes a dig at Congress leader Rahul Gandhi

RNA editing is in its nascent stage, yet there are already at least 11 biotechnology companies worldwide developing RNA editing methods for a range of diseases

Kamal Haasan is right where he left off from the first film but there is only so much he can do to salvage an already lost cause, observes Arjun Menon.

Dyson returns to India with its latest no-heat damage hair styler and dryer, the Airstrait, in Delhi. Does it deliver on its promise?

A three day exhibition, The Wedding Collective brings together over 100 different brands in fashion, jewellery, gifting, wedding design and more at the Jio World Convention Centre from August 23 to 25

The government stuck to the theme as it raised the capex outlay for the coming financial year to Rs.11.11 lakh crore, an increase of 11%

Apple users are looking for a previously mentioned ‘Sketch’ feature in the Apple Intelligence-powered Image Playground app

The early peek at data from a Phase I/II study excited families, physicians, and investors 

Directed by Raj and DK, and written by Sita R Menon, the spy series stars Varun Dhawan and Samantha, and is a prequel to Priyanka Chopra's Citadel. Citadel: Honey Bunny begins streaming from November 7 on Amazon Prime Video.

Amit Trivedi's score gives Azaad the feel of a sprawling epic that will hopefully be worth the wait, notes Mayur Sanap.

López Obrador’s fans see a champion of the poor but opponents fear a leftwing populist

A state full of parents who, having been suddenly forced to help homeschool youngsters, have by the millions grown more appreciative of the work of professional teachers in actual classrooms, had reason to worry when they heard how Gov. Cuomo trotted out plans for a Gates Foundation reinvention of public education statewide.

In this review, we try to find out if the new 2.0-litre petrol engine plonked under the hood of the Range Rover Sport takes downsizing a bit too far for a heavy 'SUV' and if this is worthy of carrying the 'Sport' tag.

It is high time to scale up the fiscal relief measures, with a special emphasis on “Basic Income”.

WBC heavyweight champion Tyson Fury has teased on social media that some "massive" news is soon to be released by his management company, sparking rumors that a title unification bout with Anthony Joshua is just around the corner.
Read Full Article at RT.com

Cleantech investing has taken quite a hit in recent years. Last year, CBS News highlighted the “cleantech crash” on U.S. primetime television, and Bloomberg New Energy Finance, a Bloomberg-owned energy data firm, has tracked the multi-year decline in cleantech investing. However, there are additional trends that tell another side of the cleantech story and suggest innovation and hope for a low-cost, low-carbon future are far from gone.

Every year for the past 20, Rosa Maria Fuenzalida has visited her mother's grave on Mother's Day without fail in the central Chilean city of Curico.

This crisis is different; a collapse of financial systems didn't spur it, a pandemic did. The government shut almost everything down, understandably so. But — at least for those advocating for help — it means government bears an increased responsibility to help businesses hurt by that shutdown.

As hundreds of test kits claim to offer accurate results on previous Covid-19 infection, scientists around the world are working hard to assess their accuracy

• Coronavirus – latest updates
• See all our coronavirus coverage

At the Erasmus University Medical Centre in Rotterdam, Marion Koopmans and a team of scientists are going throught the laborious process of verifying antibody tests for Covid-19. Over the last two months, dozens of prospective tests have hit the market, and with many governments wanting to feed the results of large-scale testing into their decisions whether to end lockdowns, biological tests have rarely carried such weight.

Most of the tests are enthusiastically marketed, boasting of their ability to accurately detect whether someone has previously been infected with the Sars-CoV-2 virus. The painstaking job of proving whether the tests do what they say has fallen to a worldwide network of 12 independent centres, of which Koopmans’s team is one.

A two-week course of antiviral therapy that combines the power of three drugs has shown promise in treating hospitalised patients with mild to moderate COVID-19 in a carefully undertaken phase 2 clinical trial.

The results of the trial, published in the journal The Lancet, involved 127 adults from six public hospitals in Hong Kong.

The drug combination tested in the trial included interferon beta-1b, which was developed to treat multiple sclerosis (MS), and lopinavir-ritonavir, which is normally used to treat HIV and ribavirin, an oral hepatitis C virus drug.

The findings of the phase two trial provided evidence that early treatment with triple antiviral therapy alongside standard care is safe and shortens duration of viral shedding (when the virus is detectable and potentially transmissible) compared to lopinavir-ritonavir alone—average seven days vs 12 days—in patients with mild to moderate COVID-19.

"Our trial demonstrates that early treatment of mild to moderate COVID-19 with a triple combination of antiviral drugs may rapidly suppress the amount of virus in a patient's body, relieve symptoms, and reduce the risk to healthcare workers by reducing the duration and quantity of viral shedding," said professor Kwok-Yung Yuen from the University of Hong Kong who led the research.

No new cases in Hong Kong as restrictions ease

Hong Kong recorded no new COVID-19 case on Saturday, a day after the city eased restrictions. Saturday was also the 20th day in a row with no local infections. Health experts earlier suggested that Hong Kong could be considered to be free of local transmission if there were no such cases after 28 days.

Catch up on all the latest Crime, National, International and Hatke news here. Also download the new mid-day Android and iOS apps to get latest updates.

Mid-Day is now on Telegram. Click here to join our channel (@middayinfomedialtd) and stay updated with the latest news

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

In the range of commercial coffee machines, Espresso is a name which is worth to rely. This Italian flavor rules the heart of the coffee lovers’ right from its origin. Considering its charm throughout the world, Espresso comes...